According to a 2013 study, both medications provided similar A1C-lowering efficacy in people with type 2 diabetes mellitus and chronic renal insufficiency. However, sitagliptin (Januvia) was generally well-tolerated, with a lower risk of hypoglycemia, compared to glipizide. READ THIS NEXT:Aptensio X...
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week resul... Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANATA-SU): 52...